Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Structural Heart Devices Market, by Type
6.1 Introduction
6.2 Heart Valve Devices
6.2.1 Transcatheter Heart Valves
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.2.2 Surgical Heart Valves
6.2.2.1 Tissue Heart Valves
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.2.2.2 Mechanical Heart Valves
Market Estimates & Forecast, by Region, 2018
Market Estimates & Forecast, by Country, 2023-2030
6.3 Occluders and Delivery Systems
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.4 Annuloplasty Rings
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.5 Accessories
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.6 Other Devices
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
Chapter 7. Global Structural Heart Devices Market, by Indication
7.1 Introduction
7.2 Valvular Heart Disease
7.2.1 Regurgitation
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.2.1 Stenosis
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.3 Cardiomyopathy
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.4 Congenital Heart Defects
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.5 Others
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
Chapter 8. Global Structural Heart Devices Market, by Procedure
8.1 Introduction
8.2 Replacement Procedures
8.2.1 TAVR Procedures
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
8.2.2 SAVR Procedures
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
8.3 Repair Procedures
8.3.1 Closure Procedures
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
8.3.2 Annuloplasty
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
8.3.3 Valvuloplasty
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
8.3.4 TMVR Procedures
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
Chapter 9. Global Structural Heart Devices Market, by End-Users
9.1 Introduction
9.2 Hospitals
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
9.3 Ambulatory Surgery Centers
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
9.4 Others
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
Chapter 10. Global Structural Heart Devices, by Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 US
10.2.1.2 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 UK
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia-Pacific
10.5 Middle East & Africa
10.5.1 Middle East
10.5.2 Africa
Chapter 11. Company Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Key Development & Strategies
Chapter 12. Company Profiles
12.1 Edwards Lifesciences Corporation
12.1.1 Company Overview
12.1.2 Type Overview
12.1.3 Financials Overview
12.1.4 Key Developments
12.1.5 SWOT Analysis
12.2 Medtronic plc
12.2.1 Company Overview
12.2.2 Type Overview
12.2.3 Financial Overview
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.3 Abbott
12.3.1 Company Overview
12.3.2 Type Overview
12.3.3 Financial Overview
12.3.4 Key Development
12.3.5 SWOT Analysis
12.4 Boston Scientific Corporation
12.4.1 Company Overview
12.4.2 Technology/Business Segment Overview
12.4.3 Financial Overview
12.4.4 Key Development
12.4.5 SWOT Analysis
12.5 LivaNova plc
12.5.1 Company Overview
12.5.2 Type Overview
12.5.3 Financial overview
12.5.4 Key Developments
12.5.5 SWOT Analysis
12.6 ST. Jude Medical
12.6.1 Company Overview
12.6.2 Type Overview
12.6.3 Financial Overview
12.6.4 Key Developments
12.6.5 SWOT Analysis
12.7 Biomerics
12.7.1 Overview
12.7.2 Type Overview
12.7.3 Financial Overview
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.8 Comed BV
12.8.1 Overview
12.8.2 Type/ Technology Overview
12.8.3 Financials
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.9 JenaValve Technology, Inc.
12.9.1 Overview
12.9.2 Type Overview
12.9.3 Financials
12.9.4 Key Developments
12.9.5 SWOT Analysis
12.10 CardioKinetix
12.10.1 Overview
12.10.2 Type Overview
12.10.3 Financials
12.10.4 Key Developments
12.10.5 SWOT Analysis
12.12 Cook Group Incorporated
12.12.1 Overview
12.12.2 Type Overview
12.12.3 Financials
12.12.4 Key Developments
12.12.5 SWOT Analysis
12.12 Endologix Inc.
12.12.1 Overview
12.12.2 Type Overview
12.12.3 Financials
12.12.4 Key Developments
12.12.5 SWOT Analysis
12.13 W. L. Gore & Associates, Inc.
12.13.1 Overview
12.13.2 Type Overview
12.13.3 Financials
12.13.4 Key Developments
12.13.5 SWOT Analysis
Chapter 13 MRFR Conclusion
13.1 Key Findings
13.1.1 From CEO’s Viewpoint
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Predictions for the Biosurgery Industry
Chapter 14. Appendix
LIST OF TABLES
Table 1 Global Structural Heart Devices Synopsis, 2023-2030
Table 2 Global Structural Heart Devices Estimates and Forecast, 2023-2030 (USD Million)
Table 3 Global Structural Heart Devices, by Region, 2023-2030 (USD Million)
Table 4 Global Structural Heart Devices, by Type, 2023-2030 (USD Million)
Table 5 Global Structural Heart Devices, by Indication, 2023-2030 (USD Million)
Table 6 Global Structural Heart Devices, by Procedure, 2023-2030 (USD Million)
Table 7 Global Structural Heart Devices, by End-users, 2023-2030 (USD Million)
Table 8 North America: Structural Heart Devices, by Type, 2023-2030 (USD
Million)
Table 9 North America: Structural Heart Devices, by Indication, 2023-2030 (USD
Million)
Table 10 North America: Structural Heart Devices, by Procedure, 2023-2030 (USD
Million)
Table 11 North America: Structural Heart Devices, by End-users, 2023-2030 (USD Million)
Table 12 US: Structural Heart Devices, by Type, 2023-2030 (USD Million)
Table 13 US: Structural Heart Devices, by Indication, 2023-2030 (USD Million)
Table 14 US: Structural Heart Devices, by Procedure, 2023-2030 (USD Million)
Table 15 US: Structural Heart Devices, by End-users, 2023-2030 (USD Million)
Table 16 Canada: Structural Heart Devices, by Type, 2023-2030 (USD Million)
Table 17 Canada: Structural Heart Devices, by Indication, 2023-2030 (USD Million)
Table 18 Canada: Structural Heart Devices, by Procedure, 2023-2030 (USD
Million)
Table 19 Canada Structural Heart Devices, by End-users, 2023-2030 (USD Million)
Table 20 South America: Structural Heart Devices, by Type, 2023-2030 (USD
Million)
Table 21 South America: Structural Heart Devices, by Indication, 2023-2030 (USD
Million)
Table 22 South America: Structural Heart Devices, by Procedure, 2023-2030 (USD
Million)
Table 23 South America: Structural Heart Devices, by End-users, 2023-2030 (USD Million)
Table 24 Europe: Structural Heart Devices, by Type, 2023-2030 (USD Million)
Table 25 Europe: Structural Heart Devices, by Indication, 2023-2030 (USD Million)
Table 26 Europe: Structural Heart Devices, by Procedure, 2023-2030 (USD Million)
Table 27 Europe: Structural Heart Devices, by End-users, 2023-2030 (USD Million)
Table 28 Western Europe: Structural Heart Devices, by Type, 2023-2030 (USD
Million)
Table 29 Western Europe: Structural Heart Devices, by Indication, 2023-2030 (USD
Million)
Table 30 Western Europe: Structural Heart Devices, by Procedure, 2023-2030
(USD Million)
Table 31 Western Europe: Structural Heart Devices, by End-users, 2023-2030 (USD Million)
Table 32 Eastern Europe: Structural Heart Devices, by Type, 2023-2030 (USD
Million)
Table 33 Eastern Europe: Structural Heart Devices, by Indication, 2023-2030 (USD
Million)
Table 34 Eastern Europe: Structural Heart Devices, by Procedure, 2023-2030
(USD Million)
Table 35 Eastern Europe: Structural Heart Devices, by End-users, 2023-2030 (USD Million)
Table 36 Asia-Pacific: Structural Heart Devices, by Type, 2023-2030 (USD
Million)
Table 37 Asia-Pacific: Structural Heart Devices, by Indication, 2023-2030 (USD
Million)
Table 38 Asia-Pacific: Structural Heart Devices, by Procedure, 2023-2030 (USD
Million)
Table 39 Asia-Pacific: Structural Heart Devices, by End-users, 2023-2030 (USD Million)
Table 40 Middle East & Africa: Structural Heart Devices, by Type, 2023-2030
(USD Million)
Table 41 Middle East & Africa: Structural Heart Devices, by Indication, 2023-2030
(USD Million)
Table 42 Middle East & Africa: Structural Heart Devices, by Procedure, 2023-2030
(USD Million)
Table 43 Middle East & Africa Structural Heart Devices, by End-users, 2023-2030 (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Structural Heart Devices
Figure 3 Segmentation Market Dynamics for Global Structural Heart Devices
Figure 4 Global Structural Heart Devices Share, by Type, 2020
Figure 5 Global Structural Heart Devices Share, by Indication, 2020
Figure 6 Global Structural Heart Devices Share, by Procedure, 2020
Figure 7 Global Structural Heart Devices, by End-users, 2023-2030 (USD Million)
Figure 8 Global Structural Heart Devices Share, by Region, 2020
Figure 9 North America: Structural Heart Devices Share, by Country, 2020
Figure 10 Europe: Structural Heart Devices Share, by Country, 2020
Figure 11 Asia-Pacific: Structural Heart Devices Share, by Country, 2020
Figure 12 Middle East & Africa: Structural Heart Devices Share, by Country, 2020
Figure 13 Global Structural Heart Devices: Company Share Analysis, 2020 (%)
Figure 14 Edwards Lifesciences Corporation: Key Financials
Figure 15 Edwards Lifesciences Corporation Segmental Revenue
Figure 16 Edwards Lifesciences Corporation: Geographical Revenue
Figure 17 Medtronic plc.: Key Financials
Figure 18 Medtronic plc.: Segmental Revenue
Figure 19 Medtronic plc.: Geographical Revenue
Figure 20 Abbott: Key Financials
Figure 21 Abbott: Segmental Revenue
Figure 22 Abbott: Geographical Revenue
Figure 23 Boston Scientific Corporation: Key Financials
Figure 24 Boston Scientific Corporation: Segmental Revenue
Figure 25 Boston Scientific Corporation: Geographical Revenue
Figure 26 LivaNova plc.: Key Financials
Figure 27 LivaNova plc.: Segmental Revenue
Figure 28 LivaNova plc.: Geographical Revenue
Figure 29 ST. Jude Medical: Key Financials
Figure 30 ST. Jude Medical: Segmental Revenue
Figure 31 ST. Jude Medical: Geographical Revenue
Figure 32 Biomerics: Key Financials
Figure 33 Biomerics: Segmental Revenue
Figure 34 Biomerics: Geographical Revenue
Figure 35 Comed BV: Key Financials
Figure 36 Comed BV Segmental Revenue
Figure 37 Comed BV: Geographical Revenue
Figure 38 JenaValve Technology, Inc.: Key Financials
Figure 39 JenaValve Technology, Inc.: Segmental Revenue
Figure 40 JenaValve Technology, Inc.: Geographical Revenue
Figure 41 CardioKinetix: Key Financials
Figure 42 CardioKinetix: Segmental Revenue
Figure 43 CardioKinetix: Geographical Revenue
Figure 44 Cook Group Incorporated: Key Financials
Figure 45 Cook Group Incorporated: Segmental Revenue
Figure 46 Cook Group Incorporated: Geographical Revenue
Figure 47 Endologix Inc.: Key Financials
Figure 48 Endologix Inc.: Segmental Revenue
Figure 49 Endologix Inc.: Geographical Revenue
Figure 50 W.L. Gore & Associates: Key Financials
Figure 51 W.L. Gore & Associates: Segmental Revenue
Figure 52 W.L. Gore & Associates: Geographical Revenue